"Chloramphenicol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
| Descriptor ID |
D002701
|
| MeSH Number(s) |
D02.033.455.706.300 D02.455.426.559.389.565.175 D02.640.529.175
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chloramphenicol".
Below are MeSH descriptors whose meaning is more specific than "Chloramphenicol".
This graph shows the total number of publications written about "Chloramphenicol" by people in this website by year, and whether "Chloramphenicol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chloramphenicol" by people in Profiles.
-
Source tracking of extensively drug resistant Salmonella Typhi in food and raw vegetables using molecular approaches. J Infect Dev Ctries. 2024 02 29; 18(2):227-234.
-
Detection of Genes Encoding Microbial Surface Component Recognizing Adhesive Matrix Molecules in Methicillin-Resistant Staphylococcus aureus Isolated from Pyoderma Patients. Genes (Basel). 2023 03 24; 14(4).
-
Monitoring bacterial resistance to chloramphenicol and other antibiotics by liquid chromatography electrospray ionization tandem mass spectrometry using selected reaction monitoring. J Mass Spectrom. 2013 Jun; 48(6):732-9.
-
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome. Eur J Haematol. 2006 Mar; 76(3):255-7.
-
Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev. 2004; (2):CD001832.
-
ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells. J Biol Chem. 2002 Jun 14; 277(24):21325-31.
-
Treatment of meningitis and other infections due to ampicillin-resistant Haemophilus influenzae type b in children. Rev Infect Dis. 1991 Mar-Apr; 13(2):197-200.
-
Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr. 1988 May; 112(5):795-8.
-
RepC is rate limiting for pT181 plasmid replication. Plasmid. 1986 Sep; 16(2):108-15.
-
Lung abscess due to Haemophilus influenzae type C. Am J Dis Child. 1979 Jun; 133(6):650-1.